ArticleAntimicrobial agents and chemotherapy2024
Mutant prevention concentrations,
Abstract read
In one paragraph
Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Addressing therapeutic options for KPC-3-producing ST307-Antimicrobial agents and chemotherapy · 2026Article
- Performance evaluation of antimicrobial susceptibility testing methods for ceftazidime-avibactam and imipenem-relebactam against Klebsiella pneumoniae and Pseudomonas aeruginosa.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Suboptimal ceftazidime-avibactam exposure drives sequentialMicrobiology spectrum · 2026Article
- Novel Insights into Carbapenem Resistance: Mechanisms, Diagnostics, and Future Directions.Antibiotics (Basel, Switzerland) · 2026Review
- In vivo evolution of resistance to novel β-lactam/β-lactamase inhibitor combinations through overproduction of the horizontally acquired extended-spectrum AmpC β-lactamase FOX-14 and porin disruption in Serratia marcescens.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Emergence of OXA-48-producingFrontiers in cellular and infection microbiology · 2026Article
- Broad spectrum of β-lactamase coverage and potent antimicrobial activity of xeruborbactam in combination with meropenem against carbapenemase-producing Enterobacterales, including strains resistant to new β-lactam/β-lactamase inhibitor combinations.Antimicrobial agents and chemotherapy · 2025Article
- Emerging resistance to novel β-lactam β-lactamase inhibitor combinations in Klebsiella pneumoniae bearing KPC variants.Journal of global antimicrobial resistance · 2025Article
- ICU environment as a reservoir of KPC-ST307-Klebsiella pneumoniae high-risk clone resistant to ceftazidime-avibactam.Scientific reports · 2025Article
- Impact of the double deletion ΔG242-T243 in KPC-2 in the effectiveness of ceftazidime-avibactam and imipenem-relebactam.Antimicrobial agents and chemotherapy · 2025Article
- Report of High-Risk Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Tania Blanco-Martín *Servicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.ORCID 0009-0003-1636-6429
Lucía González-Pinto *Servicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.ORCID 0000-0002-8387-3784
Pablo Aja-Macaya *Servicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
Salud Rodríguez-PallaresServicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
Lucía Sánchez-PeñaServicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
Eva GatoServicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
María Del Carmen Fernández-LópezServicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
Michelle Outeda-GarcíaServicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
Arianna Rodríguez-CoelloServicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
Rosa Pedraza-MerinoUnidad de Microbiología, Hospital Universitario Reina Sofía e Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
Isaac Alonso-GarcíaServicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
Juan Carlos Vázquez-UchaServicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
Luis Martínez-MartínezUnidad de Microbiología, Hospital Universitario Reina Sofía e Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
Jorge Arca-SuárezServicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.ORCID 0000-0002-4248-503X
Alejandro BeceiroServicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.ORCID 0000-0002-6340-7815
Germán BouServicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.ORCID 0000-0001-8837-0062
Funding
Axencia Galega de Innovación (GAIN) IN606A 2023/023Axencia Galega de Innovación (GAIN) IN606A 2024/022Axencia Galega de Innovación (GAIN) IN606B 2022/009Axencia Galega de Innovación (GAIN) IN607A 2016/22Axencia Galega de Innovación (GAIN) IN607D 2021/12Axencia Galega de Innovación (GAIN) IN607D 2024/008Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC) CB21/13/00049Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC) CB21/13/00055MEC | Instituto de Salud Carlos III (ISCIII) CM21/00076MEC | Instituto de Salud Carlos III (ISCIII) CM23/00095MEC | Instituto de Salud Carlos III (ISCIII) CM23/00104MEC | Instituto de Salud Carlos III (ISCIII) CM23/00218MEC | Instituto de Salud Carlos III (ISCIII) FI23/00074MEC | Instituto de Salud Carlos III (ISCIII) JR21/00026MEC | Instituto de Salud Carlos III (ISCIII) JR23/00036MEC | Instituto de Salud Carlos III (ISCIII) PI20/00686MEC | Instituto de Salud Carlos III (ISCIII) PI20/01212MEC | Instituto de Salud Carlos III (ISCIII) PI20/01749MEC | Instituto de Salud Carlos III (ISCIII) PI21/00704MEC | Instituto de Salud Carlos III (ISCIII) PI22/01212MEC | Instituto de Salud Carlos III (ISCIII) PI23/00851MEC | Instituto de Salud Carlos III (ISCIII) PMP22/00092
Abstract
PubMed holds no abstract for this paper.
Indexed as
Anti-Bacterial AgentsAzabicyclo CompoundsBacterial Proteinsbeta-LactamasesCeftazidimeDrug CombinationsImipenemKlebsiella pneumoniaeMicrobial Sensitivity Testsbeta-Lactamase InhibitorsCarbapenemsDrug Resistance, Multiple, BacterialHumansKlebsiella InfectionsMutationPorinsAnti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo CompoundsBacterial Proteinsbeta-Lactamase Inhibitorsbeta-LactamasescarbapenemaseCarbapenemsCeftazidimeDrug CombinationsImipenemPorinsrelebactamantimicrobial resistancebeta-lactamasecarbapenemceftazidime/avibactamevolutionimipenemimipenem/relebactamKPCΩ-loop
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.